Potential Masking Effect on Dyspnoea Perception by Short- And Long-Acting Β2-Agonists in Asthma

European Respiratory Journal - United Kingdom
doi 10.1183/09031936.02.00203602
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Unaltered Perception of Dyspnoea During Treatment With Long-Acting Β2-Agonists

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

Effect of Short- And Long-Acting Inhaled Β2-Agonists on Exhaled Nitric Oxide in Asthmatic Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1997English

Do Long-Acting Β2-Adrenoceptor Agonists Enhance the Anti-Inflammatory Effect of Glucocorticoids in Asthma?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

Long-Acting 2-Agonists in Asthma: Safety Concerns

CMAJ
Medicine
2005English

Short-Acting Β2-Agonists (SABA) Bronchodilator Sales and Outdoor Mould in Central France

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2019English

Review: Regular Inhaled Long Acting 2 Agonists Are Associated With Better Outcomes Than Short Acting 2 Agonists in Adults and Children With Chronic Asthma

Evidence-based nursing
FundamentalsSkills
2003English

Long Acting Beta-2 Agonists in the Treatment of Asthma and Their Safety

Tuberkuloz ve Toraks
PulmonaryCritical CareRespiratory MedicineSurgeryIntensive Care Medicine
2011English

Abediterol (LAS100977), a Novel Long-Acting Β2-Agonist: Efficacy, Safety and Tolerability in Persistent Asthma

Respiratory Medicine
PulmonaryRespiratory Medicine
2014English

The Debate About the Use of Long-Acting Inhaled ß-Agonists in Asthma

Barcelona Respiratory Network
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy